← Eichor
Study identifier: NCT05723653 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

Condition: HIV Seropositivity  ·  Sponsor: University of Chicago

PhaseNA
Planned participants900
Who can joinAll sexes, 18 Years to 49 Years
Healthy volunteersYes

About this study

The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.

This description comes directly from the study's public registry record.

Talk to the study team

Alida Bouris, PhD  ·  773-834-4304  ·  abouris@uchicago.edu

David S Batey, PhD  ·  504-862-3485  ·  dsbatey@tulane.edu

Always discuss trial participation with your own doctor first.

Locations (7)

University of Alabama at Birmingham 1917 ClinicBirmingham, Alabama, United StatesNot Yet Recruiting
Birmingham AIDS OutreachBirmingham, Alabama, United StatesRecruiting
Thrive AlabamaHuntsville, Alabama, United StatesRecruiting
Howard Brown HealthChicago, Illinois, United StatesRecruiting
Chicago Center for HIV EliminationChicago, Illinois, United StatesRecruiting
Crown Family School of Social Work, Policy, and Practice at the University of ChicagoChicago, Illinois, United StatesNot Yet Recruiting
Tulane UniversityNew Orleans, Louisiana, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05723653